• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STERIS CORPORATION REVITAL-OX RESERT HLD; HIGH LEVEL DISINFECTANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STERIS CORPORATION REVITAL-OX RESERT HLD; HIGH LEVEL DISINFECTANT Back to Search Results
Lot Number 277543
Device Problem Insufficient Information (3190)
Patient Problem Malaise (2359)
Event Date 10/06/2015
Event Type  No Answer Provided  
Manufacturer Narrative
A steris consumable territory manager went to the user facility and found that there was no issue with the product and it was being used for its intended purpose.However the technician identified that there were not adequate air exchanges in the room where the employees were stationed with the chemistry.Section 7 of the material safety data sheet for revital-ox resert hld for handling and storage states, "avoid all eye and skin contact and do not breathe vapor and mist.Provide good ventilation in process area to prevent formation of vapor." section 8: exposure controls/personal protection states, "respiratory protection: in case of insufficient ventilation, wear suitable respiratory equipment." section 4.1 states, "first-aid measures after inhalation: remove victim to fresh air and keep at rest in a position comfortable for breathing.If not breathing, give artificial respiration.Seek medical attention immediately." section 3.4.2 of ansi/aami st58:2005/(r)2010 regarding the ventilation of processing areas and equipment states, "general room ventilation: chemical sterilants should be used in an area that is properly ventilated.Rooms in which chemical disinfection and sterilization are performed should be large enough to ensure adequate dilution of vapor and should have a minimum air exchange rate of 10 air exchanges per hour (local regulations may require a higher minimum exchange rate).Ideally, local exhaust ventilation should be located at the level of the point of discharge of the vapors and pull vapors away from the work area and not toward personnel in the room." the director of chemical hygiene for the user facility agreed with the assessment and will address the air exchange issue.Additionally the user facility indicated that they did not believe the resert hld subject of the reported event was at fault.Rather the inadequate air exchanges and prolonged exposure to the product caused the reported event.The user facility is currently taking steps to address the air exchanges/ventilation issues.
 
Event Description
The user facility reported that their staff members were not feeling well when using resert hld.No medical treatment was sought or administered for the employees subject of the reported event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
REVITAL-OX RESERT HLD
Type of Device
HIGH LEVEL DISINFECTANT
Manufacturer (Section D)
STERIS CORPORATION
7501 page avenue
st. louis MO 63133
Manufacturer (Section G)
STERIS CORPORATION
7501 page avenue
st. louis MO 63133
Manufacturer Contact
kathryn cadorette
5960 heisley road
mentor, OH 44060
4403927231
MDR Report Key5188791
MDR Text Key29875517
Report Number1937531-2015-00011
Device Sequence Number1
Product Code MED
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type user facility
Reporter Occupation Other
Type of Report Initial
Report Date 10/29/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/29/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Lot Number277543
Date Manufacturer Received10/07/2015
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Other;
-
-